MixedTimes brings you breaking news and thought-provoking commentary from around the world - 24/7 news MixedTimes brings you breaking news and thought-provoking commentary from around the world - 24/7 news
LIVE
  • Home
  • Politics
  • Business
  • Opinion
  • Technology
  • Lifestyle
  • Entertainment
  • Video
Child Abuse Affects YouDonate

Trending Now

Yield Curve Control? Why Not...

'DOGE' Effect Accelerates As 'Deep Tristate' Jobless Claims Hit 4 Year high

Trump: Sending Tariff Letters To More Than 150 Countries

Beige Book Spells Trouble For Powell: Mentions Of "Inflation" Tumble To 4 Year Low, As Growth Concerns Mount

The AI Bubble Now Is Bigger Than The Dot Com Tech Bubble At Its Peak

Bats And Newts

US Industrial Production Surges In June

Bank of America Misses On Revenue Despite Stellar Sales And Trading Results, Projects Two Rates Cuts In NII Forecast

Renault Shock Profit Warning Sends Shares Crashing

$4 Trillion: Nvidia's Record Valuation In Context

J&J's new ketamine-like depression drug Spravato off to 'very, very strong start,' company says

Business April 16, 2019

This article is being updated.

Previous article: Zoom raises IPO price range and could now be worth almost $9 billion in debut Prev Next article: Zoom raises IPO price range, could now be worth almost $9 billion, showing investors crave profits Next

via CNBC April 16th 2019

  1. MixedTimes.com
  2. Business
  3. J&J's new ketamine-like depression drug Spravato off to 'very, very strong start,' company says
© 2015-2025 MixedTimes All Rights Reserved.
  • Home
  • Politics
  • Business
  • Opinion
  • Technology
  • Lifestyle
  • Entertainment
  • Video